MicroPort Scientific Corporation (0853.HK)

6.650 +0.010 (+0.15%) At close: 04:08PM HKT

MicroPort Scientific Corporation

1601 Zhangdong Road
Zhangjiang Hi-Tech Park
Shanghai 201203
China
86 21 3895 4600
https://www.microport.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 8,230

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Zhaohua Chang Ph.D.	Founder, Chairman & CEO	1.77M	N/A	1963
Mr. Hongbin Sun	Chief Financial Officer	1.05M	N/A	1975
Mr. Junder Chiang	Chief Human Resources Officer	N/A	N/A	1965
Mr. Jonathan H. Chen	Chief International Business Officer	N/A	N/A	1975
Dr. Qiyi Luo Ph.D.	Non - Executive Director	1.2M	N/A	1962
Ms. Wing Yan Yuen FCIS, FCS	Company Secretary	N/A	N/A	1970

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

MicroPort Scientific Corporation, an investment holding company, engages in the manufacture, marketing, and distribution of medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company's Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma products, and other professional implants and instruments. The company's Cardiac Rhythm Management Business segment offers defibrillators, cardiac resynchronization therapy devices, and pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Its Endovascular and Peripheral Vascular Devices segment provides disease solutions for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company's Neurovascular Devices segment offers neurovascular therapeutic and access devices for neurovascular diseases. Its Heart Valve Business segment provides VitaFlow Transcatheter aortic valve and delivery system, VitaFlow Liberty Transcatheter aortic valve implantation and retrievable delivery systems, Alwide Plus Balloon Catheter, various transcatheter aortic valve implantation, transcatheter mitral valve, transcatheter tricuspid valve, and surgical valve products. The company's Surgical Robot Business segment designs, develops, and commercializes surgical robots comprising robot ontology, control algorithm, electrical engineering, image-based navigation, and precision imaging. Its Surgical Devices segment researches and develops, manufactures, and sells surgical devices. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.

Corporate governance

MicroPort Scientific Corporation’s ISS governance QualityScore as of 1 May 2024 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.